MAPT and Alzheimer disease: Given strong support for heterogeneity of AD tau accumulation, SUVR summary measures focusing on tau burden in “early” Braak regions, identified based on group-averaged amnestic AD and autopsy studies, may, therefore, be insufficient for evaluating AD progression and subsequent cognitive impairment beyond memory.